FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics / edited by Douglas J. Pisano, David S. Mantus.

Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development, research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and co...

Full description

Saved in:
Bibliographic Details
Online Access: Full Text (via Taylor & Francis)
Other Authors: Pisano, Douglas J., Mantus, David
Format: eBook
Language:English
Published: New York : Informa Healthcare USA, ©2008.
Edition:2nd ed.
Subjects:

MARC

LEADER 00000cam a2200000xa 4500
001 b11549127
003 CoU
005 20210115100423.3
006 m o d
007 cr |||||||||||
008 081215s2008 nyua ob 001 0 eng d
010 |z 2008014296 
019 |a 467198454  |a 476193278  |a 646761960  |a 899155652  |a 992562226  |a 994966402  |a 1055232596  |a 1058357236  |a 1065704625  |a 1086490672 
020 |a 9781420073553  |q (electronic bk.) 
020 |a 1420073559  |q (electronic bk.) 
020 |z 1420073540  |q (Cloth) 
020 |z 9781420073546 
035 |a (OCoLC)tfe284975585 
035 |a (OCoLC)284975585  |z (OCoLC)467198454  |z (OCoLC)476193278  |z (OCoLC)646761960  |z (OCoLC)899155652  |z (OCoLC)992562226  |z (OCoLC)994966402  |z (OCoLC)1055232596  |z (OCoLC)1058357236  |z (OCoLC)1065704625  |z (OCoLC)1086490672 
037 |a tfe9780429126062 
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d OCLCQ  |d DKU  |d OCLCQ  |d IDEBK  |d E7B  |d OCLCQ  |d MERUC  |d OCLCQ  |d OCLCA  |d OCLCF  |d CRCPR  |d OCLCQ  |d OCLCO  |d EBLCP  |d MHW  |d OCLCA  |d OCLCQ  |d NLE  |d OTZ  |d OCLCO  |d OCLCQ  |d UAB  |d OCLCA  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCO  |d AU@  |d OCLCO  |d UKMGB  |d OCLCO  |d WYU  |d OCLCA  |d YDX  |d OCLCO  |d LEAUB  |d TYFRS  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA 
043 |a n-us--- 
049 |a GWRE 
050 4 |a RM301.25  |b .F37 2008eb 
245 0 0 |a FDA regulatory affairs :  |b a guide for prescription drugs, medical devices, and biologics /  |c edited by Douglas J. Pisano, David S. Mantus. 
250 |a 2nd ed. 
260 |a New York :  |b Informa Healthcare USA,  |c ©2008. 
300 |a 1 online resource (viii, 448 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
504 |a Includes bibliographical references and index. 
505 0 |a Overview of FDA and drug development / Josephine C. Babiarz and Douglas J. Pisano -- What is an IND / Charles Monahan and Josephine C. Babiarz -- Meeting with the FDA / Alberto Grignolo -- FDA medical device regulation / Barry Sall -- The development of orphan drugs / Tan T. Nguyen -- CMC sections of regulatory filings and CMC regulatory compliance during investigational and postapproval states / Prabu Nambiar and Steven R. Koepke -- Overview of the GxPs for the regulatory professional / Bob Buckley and Robert Blanks -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake -- Electronic submissions--a guide for electronic regulatory submissions to FDA / Shylendra Kumar, Yolanda Hall, and Vahé Ghahraman -- The practice of regulatory affairs / David S. Mantus -- A primer of drug/device law : what's the law and how do I find it / Josephine C. Babiarz -- FDA advisory committees / Christina A. McCarthy and David S. Mantus -- Biologics / Timothy A. Keutzer. 
520 |a Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development, research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements. Written in a jargon-free style, it draws information from a wide range of resources. It demystifies the inner workings of the FDA and facilitates an understanding of how it operates with respect to compliance and product approval. 
588 0 |a Print version record. 
610 1 0 |a United States.  |b Food and Drug Administration  |v Rules and practice. 
650 0 |a Drug development  |z United States. 
650 0 |a Pharmaceutical industry  |z United States.  |0 http://id.loc.gov/authorities/subjects/sh2008108871. 
610 1 7 |a United States.  |b Food and Drug Administration.  |2 fast  |0 (OCoLC)fst00549734. 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670. 
650 7 |a Pharmaceutical industry.  |2 fast  |0 (OCoLC)fst01060129. 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155. 
655 0 |a Electronic book. 
655 7 |a Rules.  |2 fast  |0 (OCoLC)fst01423857. 
700 1 |a Pisano, Douglas J.  |0 http://id.loc.gov/authorities/names/n00121754  |1 http://isni.org/isni/0000000022618312. 
700 1 |a Mantus, David.  |0 http://id.loc.gov/authorities/names/n2003005480  |1 http://isni.org/isni/000000003450067X. 
776 0 8 |i Print version:  |t FDA regulatory affairs.  |b 2nd ed.  |d New York : Informa Healthcare USA, ©2008  |z 9781420073546  |z 1420073540  |w (DLC) 2008014296  |w (OCoLC)217263645. 
856 4 0 |u https://colorado.idm.oclc.org/login?url=https://www.taylorfrancis.com/books/9780429126062  |z Full Text (via Taylor & Francis) 
907 |a .b115491272  |b 05-04-22  |c 01-22-21 
998 |a web  |b 04-13-21  |c b  |d b   |e -  |f eng  |g nyu  |h 0  |i 1 
907 |a .b115491272  |b 05-03-21  |c 01-22-21 
907 |a .b115491272  |b 04-13-21  |c 01-22-21 
944 |a MARS - RDA ENRICHED 
915 |a I 
956 |a Taylor & Francis eBooks 
956 |b Taylor & Francis All eBooks 
999 f f |i d59c66a9-7e0d-5ddc-872e-fbc064c36bcd  |s f8d88a99-52c9-5652-98a3-ee59f83242f6 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |e RM301.25 .F37 2008eb  |h Library of Congress classification  |i web  |n 1